Show source-provided references
7. Hyperthermia: Role and risk factor for cancer treatment
11. Evaluation of chitosan derivative microparticles encapsulating superparamagnetic Iron oxide and doxorubicin as a pH-sensitive delivery carrier in hepatic carcinoma treatment: An in vitro comparison study
10.3389/fphar.2018.01025 ↗13. Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies
10.1002/jps.23356 ↗14. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers
10.1002/jps.20745 ↗18. Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies
10.1021/acs.chemrev.5b00589 ↗19. Magnetorheology of core–shell structured carbonyl iron/polystyrene foam microparticles suspension with enhanced stability
10.1021/acs.macromol.5b01430 ↗24. Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy
10.1016/j.ijpharm.2014.08.014 ↗26. Synthesis and characterization of micron-sized monodisperse superparamagnetic polymer particles with amino groups
10.1002/pola.20803 ↗27. Multidrug delivery system based on polysaccharide nanocomplexes for controlled delivery of a combination of chemotherapeutics
10.1016/j.jddst.2019.01.003 ↗28. Modification and characterization of polystyrene-based magnetic microspheres and comparison with albumin-based magnetic microspheres
10.1016/S0304-8853(00)01223-3 ↗29. Doxorubicin loaded PEG-b-poly (4-vinylbenzylphosphonate) coated magnetic iron oxide nanoparticles for targeted drug delivery
10.1016/j.jmmm.2015.02.078 ↗30. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery
10.3390/ijms16048070 ↗32. Surface modification of polymers by reduction of diazonium salts: Polymethylmethacrylate as an example
10.1039/C3TC31492H ↗35. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption
10.1016/j.jconrel.2016.10.011 ↗